Aveanna Healthcare Inc. (AVAH)
Aveanna Healthcare Statistics
Share Statistics
Aveanna Healthcare has 195.09M shares outstanding. The number of shares has increased by 0.44% in one year.
Shares Outstanding | 195.09M |
Shares Change (YoY) | 0.44% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 89.68% |
Shares Floating | 49.44M |
Failed to Deliver (FTD) Shares | 1K |
FTD / Avg. Volume | 0.38% |
Short Selling Information
The latest short interest is 1.25M, so 0.65% of the outstanding shares have been sold short.
Short Interest | 1.25M |
Short % of Shares Out | 0.65% |
Short % of Float | 2.25% |
Short Ratio (days to cover) | 4.94 |
Valuation Ratios
The PE ratio is -82.25 and the forward PE ratio is 62.55. Aveanna Healthcare's PEG ratio is 0.89.
PE Ratio | -82.25 |
Forward PE | 62.55 |
PS Ratio | 0.44 |
Forward PS | 0.5 |
PB Ratio | -7.36 |
P/FCF Ratio | 34.15 |
PEG Ratio | 0.89 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aveanna Healthcare.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of -10.88.
Current Ratio | 0.98 |
Quick Ratio | 0.98 |
Debt / Equity | -10.88 |
Debt / EBITDA | 7.09 |
Debt / FCF | 50.46 |
Interest Coverage | 0.92 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $60.43K |
Profits Per Employee | $-326.24 |
Employee Count | 33,500 |
Asset Turnover | 1.22 |
Inventory Turnover | n/a |
Taxes
Income Tax | 16M |
Effective Tax Rate | 315.48% |
Stock Price Statistics
The stock price has increased by 126% in the last 52 weeks. The beta is 2.25, so Aveanna Healthcare's price volatility has been higher than the market average.
Beta | 2.25 |
52-Week Price Change | 126% |
50-Day Moving Average | 4.78 |
200-Day Moving Average | 4.68 |
Relative Strength Index (RSI) | 63.67 |
Average Volume (20 Days) | 263.2K |
Income Statement
In the last 12 months, Aveanna Healthcare had revenue of 2.02B and earned -10.93M in profits. Earnings per share was -0.06.
Revenue | 2.02B |
Gross Profit | 635.54M |
Operating Income | 139.79M |
Net Income | -10.93M |
EBITDA | 187.38M |
EBIT | 156.21M |
Earnings Per Share (EPS) | -0.06 |
Balance Sheet
The company has 84.29M in cash and 1.33B in debt, giving a net cash position of -1.24B.
Cash & Cash Equivalents | 84.29M |
Total Debt | 1.33B |
Net Cash | -1.24B |
Retained Earnings | -1.38B |
Total Assets | 1.66B |
Working Capital | -9.5M |
Cash Flow
In the last 12 months, operating cash flow was 32.64M and capital expenditures -6.32M, giving a free cash flow of 26.32M.
Operating Cash Flow | 32.64M |
Capital Expenditures | -6.32M |
Free Cash Flow | 26.32M |
FCF Per Share | 0.14 |
Margins
Gross margin is 31.39%, with operating and profit margins of 6.9% and -0.54%.
Gross Margin | 31.39% |
Operating Margin | 6.9% |
Pretax Margin | 0.25% |
Profit Margin | -0.54% |
EBITDA Margin | 9.26% |
EBIT Margin | 6.9% |
FCF Margin | 1.3% |
Dividends & Yields
AVAH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for AVAH is $5, which is -11.5% lower than the current price. The consensus rating is "Hold".
Price Target | $5 |
Price Target Difference | -11.5% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Scores
Altman Z-Score | 0.7 |
Piotroski F-Score | 6 |